Moleculin Biotech, Inc.
MBRX
$2.42
$0.010.42%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 33.71% | 107.53% | -28.73% | -30.32% | -54.14% |
| Total Receivables | 50.00% | -65.00% | -- | -44.44% | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 2.05% | -7.43% | -63.24% | -54.42% | -86.26% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -74.64% | -16.01% | -- | -10.07% | -- |
| Total Current Assets | 17.36% | 86.48% | -32.06% | -33.90% | -50.73% |
|
|
|||||
| Total Current Assets | 17.36% | 86.48% | -32.06% | -33.90% | -50.73% |
| Net Property, Plant & Equipment | -32.57% | -32.76% | -34.38% | -32.61% | -29.05% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 11.18% | 30.73% | -13.00% | -15.57% | -31.88% |
|
|
|||||
| Total Accounts Payable | 69.03% | 72.81% | -17.02% | 31.34% | 28.61% |
| Total Accrued Expenses | -20.14% | 0.00% | 17.32% | 45.09% | 27.26% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 13.71% | 14.17% | 13.79% | 14.29% | 13.76% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 15.46% | 27.90% | 1.59% | 37.71% | 27.51% |
|
|
|||||
| Total Current Liabilities | 15.46% | 27.90% | 1.59% | 37.71% | 27.51% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -43.25% | -37.99% | -33.85% | -30.48% | -27.56% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -99.76% | -- | 316.16% | 1,106.16% | 304.38% |
| Total Liabilities | -60.99% | 24.54% | 197.03% | 265.41% | 126.52% |
|
|
|||||
| Common Stock & APIC | 46.41% | 20.31% | 22.47% | 1.08% | 1.08% |
| Retained Earnings | -36.95% | -19.46% | -46.26% | -18.84% | -17.01% |
| Treasury Stock & Other | -36.84% | 124.39% | -1,200.00% | -280.00% | -111.11% |
| Total Common Equity | 36,050.00% | 33.89% | -459.94% | -140.47% | -99.81% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 36,050.00% | 33.89% | -459.94% | -140.47% | -99.81% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 36,050.00% | 33.89% | -459.94% | -140.47% | -99.81% |
|
|
|||||